Posttherapy 34 lymphoma patients with extranodal involvement were characterized by higher percentages of peripheral CXCR3 positive lymphocytes than those in posttherapy 44 patients without extranodal involvement (median: 78% vs. 26%, P < 0.001) (Figure 1). This evidence concerns the gene CXCR3 and lymphoma.